- CancerNetwork.com
- CureToday.com
- OncLive.com
- TargetedOnc.com
- Privacy
- Terms & Conditions
- Do Not Sell My Information
© 2022 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
University of Vermont Cancer Center
Latest from University of Vermont Cancer Center
Eribulin Elicits Promising 2-Year Overall Survival in Pretreated Metastatic Breast Cancer
March 06, 2022
Article
Real-world findings presented at the 39th Annual Miami Breast Cancer Conference showed that eribulin may be an effective agent for previously treated patients with metastatic breast cancer.